Valeant Pharmaceutical Inc’s mixed group of owners find a way to work together

For a company that has made its shareholders a lot of money – a total return of 255% over the past three years – Valeant Pharmaceuticals International Inc’s share register has a different look. Valeant to team up with Bill Ackman on sweetened bid for Salix: report Valeant Pharmaceuticals Inc is planning to team up with…